2,340 followers
Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous KIT/PDGFRA Mutations in the Phase III INVICTUS Study https://t.co/Mty0sHeOF4 #hvhebron #onco [Text complet]
27 followers
RT @CCR_AACR: Phase 3 Study: Efficacy of ripretinib against range of KIT/PDGFRA mutations (INVICTUS Study). https://t.co/GzmkYVvyue https:/…
462 followers
RT @CCR_AACR: Phase 3 Study: Efficacy of ripretinib against range of KIT/PDGFRA mutations (INVICTUS Study). https://t.co/GzmkYVvyue https:/…
91 followers
RT @CCR_AACR: Phase 3 Study: Efficacy of ripretinib against range of KIT/PDGFRA mutations (INVICTUS Study). https://t.co/GzmkYVvyue https:/…
2,666 followers
RT @CCR_AACR: Phase 3 Study: Efficacy of ripretinib against range of KIT/PDGFRA mutations (INVICTUS Study). https://t.co/GzmkYVvyue https:/…
2,352 followers
RT @CCR_AACR: Phase 3 Study: Efficacy of ripretinib against range of KIT/PDGFRA mutations (INVICTUS Study). https://t.co/GzmkYVvyue https:/…
5,953 followers
Phase 3 Study: Efficacy of ripretinib against range of KIT/PDGFRA mutations (INVICTUS Study). https://t.co/GzmkYVvyue https://t.co/eWE8wqLTU5
369 followers
Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous KIT/PDGFRA Mutations in the Phase III INVICTUS Study https://t.co/bHmdocpG2v
7,428 followers
Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous KIT/PDGFRA Mutations in the Phase III INVICTUS Study https://t.co/rei8uCFKcl
82 followers
RT @Deciphera: We’re pleased to share our recently published manuscript in @CCR_AACR on the clinical activity of QINLOCK® (ripretinib) from…
2,039 followers
RT @seppobauer: …benefit of ripretinib over placebo seen regardless of KIT resistance mutation! @CCR_AACR https://t.co/zpg9NAV2nB
270 followers
…benefit of ripretinib over placebo seen regardless of KIT resistance mutation! @CCR_AACR https://t.co/zpg9NAV2nB
2,772 followers
@seppobauer @pawel_sobczuk @Annals_Oncology @myESMO @ERN_EURACAN @OncoAlert @casali_pg @rutkowskip1972 @alegronchi @SilviaStacchia @SBonvalot @kjetilboye @annamariafrezza @EnriquedeAlava @RobinL_Jones any resistance mutations found in Rip progressers? http
2,772 followers
RT @CCR_AACR: Gastrointestinal stromal tumor patients receiving #ripretinib showed progression-free survival benefit vs placebo regardless…
5,953 followers
Gastrointestinal stromal tumor patients receiving #ripretinib showed progression-free survival benefit vs placebo regardless of mutation status and in all assessed subgroups. https://t.co/ECG4yku08u. @seppobauer @schoffski https://t.co/9NIvTSbGFz
223 followers
RT @Deciphera: We’re pleased to share our recently published manuscript in @CCR_AACR on the clinical activity of QINLOCK® (ripretinib) from…
700 followers
We’re pleased to share our recently published manuscript in @CCR_AACR on the clinical activity of QINLOCK® (ripretinib) from our Phase 3 INVICTUS study. Learn more: https://t.co/OsLymbnBNr https://t.co/1DwsEeKu2b
2,340 followers
Clinical activity of ripretinib in patients with advanced gastrointestinal stromal tumor harboring heterogenous KIT… https://t.co/BDDRdHpFr1 #hvhebron #onco [Text complet] @CCR_AACR
1,013 followers
RT @JTrentMDPhD: Clinical activity of ripretinib in patients with advanced gastrointestinal stromal tumor #GIST harboring heterogenous KIT/…
2,826 followers
RT @JTrentMDPhD: Clinical activity of ripretinib in patients with advanced gastrointestinal stromal tumor #GIST harboring heterogenous KIT/…
363 followers
RT @JTrentMDPhD: Clinical activity of ripretinib in patients with advanced gastrointestinal stromal tumor #GIST harboring heterogenous KIT/…
1,096 followers
RT @JTrentMDPhD: Clinical activity of ripretinib in patients with advanced gastrointestinal stromal tumor #GIST harboring heterogenous KIT/…
270 followers
RT @JTrentMDPhD: Clinical activity of ripretinib in patients with advanced gastrointestinal stromal tumor #GIST harboring heterogenous KIT/…
25 followers
RT @TJH43: Clinical activity of ripretinib in patients with advanced gastrointestinal stromal tumor harboring heterogenous KIT/PDGFRA mutat…
4,242 followers
RT @JTrentMDPhD: Clinical activity of ripretinib in patients with advanced gastrointestinal stromal tumor #GIST harboring heterogenous KIT/…
343 followers
RT @JTrentMDPhD: Clinical activity of ripretinib in patients with advanced gastrointestinal stromal tumor #GIST harboring heterogenous KIT/…
71 followers
Clinical activity of ripretinib in patients with advanced gastrointestinal stromal tumor harboring heterogenous KIT/PDGFRA mutations in the phase 3 INVICTUS study - 1078-0432.CCR-21-1864.full.pdf https://t.co/5fgCmPqclr
1,457 followers
RT @JTrentMDPhD: Clinical activity of ripretinib in patients with advanced gastrointestinal stromal tumor #GIST harboring heterogenous KIT/…
2,039 followers
RT @JTrentMDPhD: Clinical activity of ripretinib in patients with advanced gastrointestinal stromal tumor #GIST harboring heterogenous KIT/…
5,646 followers
Clinical activity of ripretinib in patients with advanced gastrointestinal stromal tumor #GIST harboring heterogenous KIT/PDGFRA mutations @seppobauer @schoffski @jeanyvesblay @GinaDAmatoMD1 @SylvesterCancer https://t.co/rwLy6Gh01X
155 followers
PubMed_ Clinical activity of ripretinib in patients with advanced gastrointestinal stromal tumor harboring heterogenous KIT/PDGFRA mutations in the phase 3 INVICTUS study https://t.co/sKTnY2zqQl
7,428 followers
Clinical activity of ripretinib in patients with advanced gastrointestinal stromal tumor harboring heterogenous KIT/PDGFRA mutations in the phase 3 INVICTUS study https://t.co/PCJG6W3x2c